Factors modulating food intake and energy expenditure prior to liver transplantation

Authors

  • E. Santos Hospital Universitario de Burgos
  • A. Rodríguez Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • C. Prieto Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • M. J. Gil Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • G. Fruhbeck Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • J. Quiroga Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • J. I. Herrero Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA
  • J. Salvador Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

DOI:

https://doi.org/10.23938/1137-6627/2016000100012

Keywords:

cirrosis hepática, leptina, ghrelina, glucagón, IGF-I

Abstract

ABSTRACT

            Background. There is a high prevalence of nutritional disorders in patients with liver cirrhosis (LC). This study was designed to assess the relationships between liver function, IFG-I/IGFBP-3, nutritional status, leptin, ghrelin and glucagon in 21 patients waiting for liver transplantation (LT).

            Methods. We studied 21 men aged 56+2.1 years who were on the LT list. They were classified according to Child-Pugh (CP) score from low to high liver dysfunction in CPA (n=4), CPB (n=11) and CPC (n=6). Body mass index (BMI) was calculated and body fat (%) was measured by air-displacement plethysmography. Resting energy expenditure (REE) and its variation over Harris-Benedict values (GER%) was assessed by indirect calorimetry. Fasting serum samples were taken to measure albumin, glucose, insulin, HbA1c, leptin, total ghrelin, glucagon, IGF-I and IGFBP3.

            Results. There were no differences in fat % and leptin values in the three groups according to CP classification. The CPC group showed higher ghrelin values than CPA and CPB (p<0.05). All groups displayed high glucagon levels and GER% values superior to 100%. Positive correlations were found between glucagon and GER% (r=0.56; p<0.01) and between glucagon and ghrelin values (r=0.66; p<0.01). IGF-I and IGFBP3 were low in all groups and showed a positive correlation with plasma albumin (r=0.52; p<0.05 and r=0.45; p<0.05 respectively).

            Conclusions. These results show an increase in ghrelin plasma values in patients with severe liver dysfunction. Hyperglucagonemia was correlated with GER%, supporting a role of glucagon in the hypermetabolic state associated to LC, raising the possibility of becoming a therapeutic target. The measurement of IGF-I/IGFBP3 represents a good marker of liver function in patients with LC.

            Key words. Liver cirrhosis. Leptin. Ghrelin. Glucagon. IGF-I

Downloads

Download data is not yet available.

Author Biographies

E. Santos , Hospital Universitario de Burgos

Adjunto servicio Endocrinología. Hospital Universitario de Burgos

A. Rodríguez , Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Laboratorio de Investigación Metabólica. Departamento de Endocrinología. Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

C. Prieto , Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Colaborador clínico. Unidad de Hepatología. Clínica Universidad de Navarra.

M. J. Gil , Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Consultor Servicio de Bioquímica. Clínica Universidad de Navarra. Pamplona

G. Fruhbeck , Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Director Laboratorio de Investigación Metabólica. Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

J. Quiroga , Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Director del Departamento de Medicina Interna. Clínica Universidad de Navarra.  Instituto de Investigación Sanitaria de Navarra. IdiSNA

J. I. Herrero , Clínica Universidad de Navarra. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Consultor Unidad de Hepatología. Clínica Universidad de Navarra.  Instituto de Investigación Sanitaria de Navarra. IdiSNA

J. Salvador , Clínica Universidad de Navarra. CIBEROBN. Instituto Carlos III. Madrid. Instituto de Investigación Sanitaria de Navarra. IdiSNA

Director Departamento de Endocrinología y Nutrición. Clínica Universidad de Navarra. Pamplona

Published

2016-04-29

How to Cite

Santos, E., Rodríguez, A., Prieto, C., Gil, M. J., Fruhbeck, G., Quiroga, J., Herrero, J. I., & Salvador, J. (2016). Factors modulating food intake and energy expenditure prior to liver transplantation. Anales Del Sistema Sanitario De Navarra, 39(1), 105–114. https://doi.org/10.23938/1137-6627/2016000100012

Issue

Section

Short articles

Most read articles by the same author(s)

1 2 > >>